Johnson & Johnson reported strong earnings, surpassing analyst estimates and raising full-year EPS guidance. Management expressed confidence, highlighting cost savings, ongoing share repurchases, and increased dividends. These positive signals suggest a likely short-term positive impact on the stock price.
[1]